Inventor · disambiguated record
Hakan Gunaydin
Also filed as: GUNAYDIN HAKAN
15 granted patents·7 pending applications·46 citations·filing 2013–2023
88Inventor score
Files withMERCK SHARP & DOHME8RELAY THERAPEUTICS INC6AMGEN INC3MERCK SHARP & DOHME LLC3CHILDERS KALEEN KONRAD1
Top patents by PatentIndex Score
22 records- 0195US9663508B2Biaryl acyl-sulfonamide compounds as sodium channel inhibitorsAMGEN INC·Filed 2014·Granted May 30, 2017·29 cites·20 claims
- 0291US12084447B2SHP2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2020·Granted Sep 10, 2024·2 cites·20 claims
- 0385US10287272B2Substituted indazole compounds as RORgammaT inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2016·Granted May 14, 2019·3 cites·30 claims
- 0480US9505749B2Quinazolinone compounds and derivatives thereofAMGEN INC·Filed 2013·Granted Nov 29, 2016·3 cites·49 claims
- 0578US12331056B2SHP2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Granted Jun 17, 2025·0 cites·21 claims
- 0678US12030872B2N-heteroaryl indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereofMERCK SHARP & DOHME LLC·Filed 2019·Granted Jul 9, 2024·2 cites·15 claims
- 0778US11161854B2Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereofMERCK SHARP & DOHME·Filed 2018·Granted Nov 2, 2021·2 cites·10 claims
- 0878US10221142B2Substituted pyrazole compounds as RORgammaT inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2016·Granted Mar 5, 2019·3 cites·29 claims
- 0971US10344000B2Substituted bicyclic pyrazole compounds as RORgammaT inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2016·Granted Jul 9, 2019·1 cites·23 claims
- 1070US9340549B2Oxazolidinone compounds and derivatives thereofAMGEN INC·Filed 2013·Granted May 17, 2016·1 cites·10 claims
- 1167US10689369B2Substituted indazole compounds as RORgammaT inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2019·Granted Jun 23, 2020·0 cites·24 claims
- 1266US2025313524A1Pi3k-alpha inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1365US2022315586A1Shp2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1456US2025090540A1Pi3k-alpha inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1555US2024308980A1Heteroaryl amides as lrrk2 inhibitors, pharmaceutical compositions, and uses thereofMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 1654US2025019380A1Pi3k-alpha inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1751US2024174679A1Heteroaroyl amides as lrrk2 inhibitors, pharmaceutical compositions, and uses thereofCHILDERS KALEEN KONRAD·Filed 2022·Application pending·0 cites
- 1846US11174248B2Indazolyl-spiro[2.3]hexane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereofMERCK SHARP & DOHME·Filed 2018·Granted Nov 16, 2021·0 cites·11 claims
- 1945US12215116B2Arginase inhibitors and methods of useMERCK SHARP & DOHME LLC·Filed 2019·Granted Feb 4, 2025·0 cites·46 claims
- 2045US10584121B2Heteroaryl substituted benzoic acids as RORgammaT inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2016·Granted Mar 10, 2020·0 cites·23 claims
- 2145US2020048259A1Kdm5 inhibitorsMANSOOR UMAR FARUK·Filed 2017·Application pending·0 cites
- 2242US10975084B2KDM5 inhibitorsMERCK SHARP & DOHME·Filed 2017·Granted Apr 13, 2021·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Hakan Gunaydin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →